Finally, we conducted a Transwell invasion test to confirm the effect of RPL4P4 on the aggressive ability of glioma cells and found that the glioma cell invasion ability of si-RPL4P4 was significantly lower than that of the control and si-NC groups (P < 0.05) (Figures 8(h) and 8(i)). The gene discussed is RPL4P4; the disease is central nervous system cancer.